Tumour imaging by Positron Emission Tomography using fluorinase generated 5-[18F]fluoro-5-deoxyribose as a novel tracer

Nuclear Medicine and Biology

Volumn 40, Issue 4, 2013, Pages 464-470

  Dall'Angelo, Sergio ^a   Bandaranayaka, Nouchali ^b   Windhorst, Albert D ^c   Vugts, Danielle J ^c   van der Born, Dion ^c   Onega, Mayca ^a,b   Schweiger, Lutz F ^a   Zanda, Matteo ^a   O'Hagan, David ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

5 fluoro 5 deoxyribose; Biotransformation; Fluorinase; Fluorine 18; Positron emission tomography; Tumour mice models

Indexed keywords

5 FLUORO 5 DEOXADENOSINE F 18; 5 FLUORO 5 DEOXYRIBOSE F 18; ADENOSINE NUCLEOSIDASE; BUFFER; ENZYME; FLUORINASE; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; NUCLEOSIDASE; S ADENOSYLMETHIONINE; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SCREENING; CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISSOLUTION; DRUG ACCUMULATION; DRUG SYNTHESIS; DRUG TRANSPORT; DRUG UPTAKE; FREEZE DRYING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; TUMOR MODEL; TUMOR XENOGRAFT;

ANIMALS; BACTERIAL PROTEINS; BIOTRANSFORMATION; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ENZYME STABILITY; HUMANS; MICE; N-GLYCOSYL HYDROLASES; OXIDOREDUCTASES; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; RADIOCHEMISTRY; RIBOSE;

EID: 84876704071     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2013.02.006     Document Type: Article

References (24)

1. Townsend D.W. Multimodality imaging of structure and function. Phys Med Biol 2008, 53:R1-R39.
2. Sharma R., Aboagye E. Development of radiotracers for oncology - the interface with pharmacology. Brit J Pharmacol 2011, 163:1565-1585.
3. 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med 2012, 53:59-71.
4. Cavalcanti Filho J.L.G., de Souza Leão Lima R., de Souza Machado Neto L., Kayat Bittencourt L., Domingues R.C., da Fonseca L.M.B. PET/CT and vascular disease: current concepts. Eur J Radiol 2011, 80:60-67.
5. 18F] fluoride ion. Eur J Org Chem 2008, 2008:2853-2873.
6. Dong C., Huang F., Deng H., Schaffrath C., Spencer J.B., O'Hagan D., et al. Crystal structure and mechanism of a bacterial fluorinating enzyme. Nature 2004, 427:561-565.
7. O'Hagan D., Schaffrath C., Cobb S.L., Hamilton J.T.G., Murphy C.D. Enzyme catalysed organofluorine synthesis. Nature 2002, 416:279-280.
8. 18F]-5-fluoro-5-deoxyribose, an efficient peptide bioconjugation ligand for positron emission tomography (PET) imaging. Chem Commun 2012, 48:5247-5249.
9. 18F] fluorinated sugars for PET imaging. Chem Commun 2010, 139-141.
10. 18F]-fluoroacetate for PET studies. Chem Commun 2010, 46:7819-7821.
11. Onega M., Winkler M., O'Hagan D. The fluorinase: a tool for the synthesis of fluorine-18 labelled sugars and nucleosides for positron emission tomography. Future Med Chem 2009, 1:865-873.
12. 18F]-5'-deoxy-5'-fluorouridines. AngewChemInt 2008, 47:10141-10143.
13. 18F bond formation, an enzymatic tool for PET labelling. Chem Commun 2006, 111:652-654.
14. Huang B., Law M.W.-M., Khong P.-L. Whole body PET/CT scanning. Estimation of radiation dose and cancer risk. Radiology 2009, 251:166-174.
15. 18F-FDG PET for post therapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: a systematic review. J Nucl Med 2008, 49:13-21.
16. Ashton T.D., Scammells P.J. An improved synthesis of 5'-fluoro-5'-deoxyadenosines. Bioorg Med Chem Lett 2005, 15:3361-3363.
17. Sharma M., Li Y.X., Ledvina M., Bobek M. Synthesis of 5'-fluoro-5'-deoxy- and 5'-amino-5'-deoxytoyocamycin and sangivamycin and some related derivatives. Nucleosides Nucleotides 1995, 14:1831-1852.
18. Versées W., Decanniere K., Pellé R., Depoorter J., Brosens E., Parkin D.W., et al. Structure and function of a novel purine specific nucleoside hydrolase from Trypanosoma vivax. J Mol Biol 2001, 307:1363-1379.
19. Iovane E., Giabbai B., Muzzolini L., Matafora V., Fornili A., Degano M., et al. Arabidopsis thaliana nucleosidase mutants provide new insights into nucleoside degradation. Biochemistry 2008, 47:4418-4426.
20. Windhorst A.D., Linden T.T., de Nooij A., Keus J.F., Buijs F.L., Schollema P.E., et al. A complete, multipurpose, low cost, fully automated and GMP compliant radiosynthesis system. J Labelled Comp Radiopharm 2001, 44:S1052-S1054.
21. Theobald J., Hanby A., Patel K., Moss S.E. Annexin VI has tumour-suppressor activity in human A431 squamous epithelial carcinoma cells. Br J Cancer 1995, 71:86-788.
22. Fan S., Qi M., Yu Y., Li L., Yao G., Ikejima T., et al. P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK. Free Radic Res 2012, 46:310-319.
23. Kuwabara H., Gjedde A. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate. J Nucl Med 1991, 32:692-698.
24. Naula C.M., Logan F.M., Wong P.E., Barrett M.P., Burchmore R.J. A glucose transporter can mediate ribose uptake. Definition of residues that confer substrate specificity in a sugar transporter. J Biol Chem 2010, 285:29721-29728.